Prognostic and predictive factors associated with ipilimumab-related adverse events: a retrospective analysis of 11 NCI-sponsored phase I clinical trials

Background: We review factors impacting ipilimumab-associated adverse events through the experience from National Cancer Institute (NCI)-sponsored phase I immunotherapy clinical trials. Materials and Methods: Attributable ipilimumab-related adverse events from NCI-sponsored phase I immunotherapy cli...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Chauhan, Aman, Kabir, Tanvir, Wu, Jianrong, Wei, Jing, Cook, Mary, Kunos, Charles A.
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2020
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7185063/
https://ncbi.nlm.nih.gov/pubmed/32363000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27537
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky